Neil Josephson - 16 May 2021 Form 3 Insider Report for Zymeworks Inc.

Role
Interim Chief Medical Officer
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 May 2021
Net transactions value
$0
Form type
3
Filing time
25 May 2021, 21:00:22 UTC
Next filing
08 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZYME Common Shares 1,593 16 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZYME Stock Option (Right to Buy) 16 May 2021 Common Shares 80,000 $19.11 Direct F1
holding ZYME Stock Option (Right to Buy) 16 May 2021 Common Shares 13,125 $35.20 Direct F2
holding ZYME Stock Option (Right to Buy) 16 May 2021 Common Shares 30,000 $34.82 Direct F3
holding ZYME Stock Option (Right to Buy) 16 May 2021 Common Shares 15,000 $29.49 Direct F4
holding ZYME Restricted Stock Unit 16 May 2021 Common Shares 1,459 Direct F5, F6
holding ZYME Restricted Stock Unit 16 May 2021 Common Shares 5,000 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: (i) 25% on May 6, 2020 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.
F2 Stock options vest as follows: (i) 25% on March 10, 2021 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.
F3 Stock options vest as follows: (i) 25% on March 10, 2022 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.
F4 Stock options vest as follows: (i) 25% on May 6, 2022 (the first anniversary of grant date) and (ii) remainder in 36 equal monthly installments on last day of each month following first anniversary of grant date.
F5 The restricted stock units vest in two equal annual installments beginning on March 10, 2022.
F6 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F7 The restricted stock units vest in three equal annual installments beginning on March 10, 2022.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney